Evidence map›Paper›PMID 41090186›Full record

ReviewFASEB bioAdvances2025

Calumenin, A Calcium-Binding Modulatory Protein, Effective in Pathological Calcifications and Cancers, With Therapeutic Application Promise.

Parinaz Nasri Nasrabadi, Babak Jahangiri, Zahra Amiri, Forouzandeh Mahjoubi, Fatemeh Masoumi, Alireza Zomorodipour

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in FASEB bioAdvances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Parinaz Nasri NasrabadiDepartment of Molecular Medicine Institute of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology Tehran Iran.
Babak JahangiriDepartment of Molecular Medicine Institute of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology Tehran Iran.
Zahra AmiriDepartment of Molecular Medicine Institute of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology Tehran Iran.
Forouzandeh MahjoubiDepartment of Medical Genetics Institute of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology Tehran Iran.
Fatemeh MasoumiDepartment of Molecular Medicine Institute of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology Tehran Iran.
Alireza ZomorodipourDepartment of Molecular Medicine Institute of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology Tehran Iran.ORCID https://orcid.org/0000-0003-0671-4779

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Calumenin (CALU), a multifunctional E-F-hand protein of the CREC family involved in various cellular processes, is ubiquitously expressed in almost all human tissues, although its expression level is tissue-specific. CALU plays an effective role in calcium (Ca) homeostasis throughout various Ca2

Indexed as

Ca2+‐bindingCa depositioncalcium ion homeostasisCALU isoformscalumenincancerendoplasmic/sarcoplasmic reticulum‐related processesER stressγ‐carboxylation

Identifiers

PMID41090186
PMCPMC12516920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.